Claims for Patent: 11,571,531
✉ Email this page to a colleague
Summary for Patent: 11,571,531
| Title: | Powder delivery devices |
| Abstract: | A nasal delivery device for delivering substance to a nasal cavity of a subject, the delivery device comprising: a substance supply unit for supplying a dose of substance to be delivered to the nasal cavity of the subject, the substance supply unit including an inlet and an outlet; a nosepiece unit including a nosepiece for fitting to a nasal cavity of the subject and being in fluid communication with the outlet of the substance supply unit; and a mouthpiece unit including a mouthpiece in fluid communication with the inlet of the substance supply unit and through which the subject in use exhales such as to entrain substance from the container chamber and deliver the same through the nosepiece, and at least one temperature modifier for reducing a temperature of the exhaled air flow such as to reduce the absolute humidity thereof. |
| Inventor(s): | Per Gisle Djupesland, Roderick Peter Hafner, Colin David Sheldrake |
| Assignee: | Optinose Inc |
| Application Number: | US15/879,009 |
| Patent Claims: |
1. A method of delivering powdered substance to a nasal cavity of a subject, the method comprising: rupturing a powdered substance-containing container within a substance supply unit of a delivery device, wherein the delivery device comprises: the substance supply unit for supplying a dose of powdered substance to be delivered to the nasal cavity of the subject, the substance supply unit including an inlet and an outlet; a nosepiece unit including a nosepiece for fitting to the nasal cavity of the subject and being in fluid communication with the outlet of the substance supply unit; and a mouthpiece unit including a mouthpiece in fluid communication with the inlet of the substance supply unit and through which the subject in use exhales such as to entrain powdered substance from the substance supply unit and deliver the same through the nosepiece; wherein the substance supply unit comprises a container chamber for receiving the powdered substance-containing container which contains a dose of powdered substance, and the container or an outer coating on a body of the container is formed of a material which exhibits insufficient tackiness in the presence of moisture so as not to adhere to an inner surface of the container chamber during emptying of the powdered substance from the container; fitting the nosepiece unit of the delivery device to the nasal cavity of the subject; and the subject exhaling through the mouthpiece unit such as to entrain powdered substance from the substance supply unit and deliver the same through the nosepiece to the nasal cavity of the subject. 2. The method of claim 1, wherein the container chamber is substantially cylindrical in shape or substantially spherical in shape. 3. The method of claim 1, wherein the substance supply unit comprises a rupturing mechanism for rupturing the container as contained in the container chamber. 4. The method of claim 1, wherein the container or the outer coating of the container is formed of a material which exhibits insufficient tackiness in the presence of moisture in the exhalation air flow for a period of (i) up to about 5 s following exhalation, (ii) up to about 2 s following exhalation, or (iii) up to about 1 s following exhalation. 5. The method of claim 4, wherein the container or the body of the container is formed substantially of a cellulose derivative, optionally one or more of hydroxypropyl methylcellulose (HPMC), hydroxypropylcellulose, methylcellulose, ethylcellulose and carboxymethylcellulose. 6. The method of claim 4, wherein the coating comprises substantially one of parylene, hydroxypropyl methylcellulose (HPMC), hydroxypropylcellulose, methylcellulose, ethylcellulose, carboxymethylcellulose, polyvinyl alcohol, acrylic acid polymer, methacrylic acid polymer, ethyl acrylic acid polymer, cellulose acetate phthalate, polyvinyl acetate phthalate, hydroxypropyl methylcellulose phthalate and hydroxyl methylcellulose acetate succinate, or any combination of layers thereof. 7. The method of claim 1, wherein the container comprises a capsule, optionally the capsule is substantially cylindrical in shape or substantially spherical in shape. 8. The method of claim 1, wherein the powdered substance is a hygroscopic powder. 9. The method of claim 1, wherein the container or the body of the container comprises a cellulose derivative. 10. The method of claim 1, wherein the container or the body of the container comprises hydroxypropyl methylcellulose (HPMC). 11. The method of claim 1, wherein the container or the body of the container comprises one or more of hydroxypropylcellulose, methylcellulose, ethylcellulose and carboxymethylcellulose. 12. The method of claim 1, wherein the container or the body of the container comprises methylcellulose. 13. The method of claim 1, wherein the container or the body of the container comprises ethylcellulose. 14. The method of claim 1, wherein the container or the body of the container comprises carboxymethylcellulose. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
